IDEXX Laboratories, Inc. (IDXX)
676.04
+5.33
(+0.79%)
USD |
NASDAQ |
Nov 06, 16:00
677.73
+1.69
(+0.25%)
After-Hours: 20:00
IDEXX Laboratories Cash from Operations (Quarterly) : 449.72M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 449.72M |
| June 30, 2026 | 347.16M |
| March 31, 2026 | 266.25M |
| December 31, 2025 | 352.02M |
| September 30, 2025 | 402.34M |
| June 30, 2025 | 185.74M |
| March 31, 2025 | 237.96M |
| December 31, 2024 | 262.02M |
| September 30, 2024 | 220.08M |
| June 30, 2024 | 248.31M |
| March 31, 2024 | 198.58M |
| December 31, 2023 | 249.85M |
| September 30, 2023 | 272.43M |
| June 30, 2023 | 200.31M |
| March 31, 2023 | 183.91M |
| December 31, 2022 | 172.99M |
| September 30, 2022 | 189.00M |
| June 30, 2022 | 65.85M |
| March 31, 2022 | 114.71M |
| December 31, 2021 | 207.31M |
| September 30, 2021 | 187.20M |
| June 30, 2021 | 233.96M |
| March 31, 2021 | 124.42M |
| December 31, 2020 | 218.93M |
| September 30, 2020 | 193.12M |
| Date | Value |
|---|---|
| June 30, 2020 | 208.14M |
| March 31, 2020 | 27.87M |
| December 31, 2019 | 155.41M |
| September 30, 2019 | 132.26M |
| June 30, 2019 | 137.10M |
| March 31, 2019 | 34.38M |
| December 31, 2018 | 135.65M |
| September 30, 2018 | 110.71M |
| June 30, 2018 | 118.83M |
| March 31, 2018 | 34.90M |
| December 31, 2017 | 121.13M |
| September 30, 2017 | 110.68M |
| June 30, 2017 | 110.19M |
| March 31, 2017 | 31.27M |
| December 31, 2016 | 100.12M |
| September 30, 2016 | 100.32M |
| June 30, 2016 | 110.92M |
| March 31, 2016 | 23.17M |
| December 31, 2015 | 73.90M |
| September 30, 2015 | 76.95M |
| June 30, 2015 | 80.17M |
| March 31, 2015 | -14.64M |
| December 31, 2014 | 27.30M |
| September 30, 2014 | 93.26M |
| June 30, 2014 | 81.76M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -- |
| DexCom, Inc. | 325.60M |
| Abbott Laboratories | 1.737B |
| Intuitive Surgical, Inc. | 1.224B |
| Teleflex, Inc. | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -248.10M |
| Cash from Financing (Quarterly) | -200.85M |
| Free Cash Flow | 1.296B |
| Free Cash Flow Per Share (Quarterly) | 5.323 |
| Free Cash Flow to Equity (Quarterly) | 543.90M |
| Free Cash Flow to Firm (Quarterly) | 427.65M |
| Free Cash Flow Yield | 2.40% |